Whelton PK, Carey RM, Aronow WS. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
Williams B, Mancia G, Spiering W. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
Unger T, Borghi C, Charchar F. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334-1357.
James PA, Oparil S, Carter BL. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
Armstrong C. High blood pressure: ACC/AHA releases updated guideline. Am Fam Physician. 2018;97(6):413-415.
- Coles S, Fisher L, Lin K, Lyon C, Vosooney A, Bird MD. Blood pressure targets in adults with hypertension: a clinical practice guideline from the AAFP. Am Fam Physician. 2022. Online ahead of print. https://www.aafp.org/dam/AAFP/documents/journals/afp/AAFPHypertensionGuideline.pdf
Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018 https://www.cdc.gov/nchs/products/databriefs/db364.htm
National Center for Health Statistics. National Ambulatory Medical Care Survey: 2014 State and National Summary Tables https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2014_namcs_web_tables.pdf
Krist AH, Davidson KW, Mangione CM. Screening for hypertension in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325(16):1650-1656.
Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(10):e2021476.
Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension. 2005;45(4):499-504.
Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011;24(2):123-134.
Shimbo D, Artinian NT, Basile JN. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63.
Guo X, Zhang X, Guo L. Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Curr Hypertens Rep. 2013;15(6):703-716.
Gay HC, Rao SG, Vaccarino V, Ali MK. Effects of different dietary interventions on blood pressure: systematic review and meta-analysis of randomized controlled trials. Hypertension. 2016;67(4):733-739.
Arnett DK, Blumenthal RS, Albert MA. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376-1414.
Lee LL, Mulvaney CA, Wong YKY, Chan ESY, Watson MC, Lin HH. Walking for hypertension. Cochrane Database Syst Rev. 2021(2):CD008823.
Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2(2):e108-e120.
Tsai SY, Huang WH, Chan HL, Hwang LC. The role of smoking cessation programs in lowering blood pressure: a retrospective cohort study. Tob Induc Dis. 2021;19:82.
Jones DW, Whelton PK, Allen N. Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: filling a guidance gap: a scientific statement from the American Heart Association. Hypertension. 2021;77(6):e58-e67.
Wright JT, Williamson JD, Whelton PK. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-2116.
Lewis CE, Fine LJ, Beddhu S. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384(20):1921-1930.
Albasri A, Hattle M, Koshiaris C. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372(189).
Batterink J, Stabler SN, Tejani AM, Fowkes CT. Spironolactone for hypertension. Cochrane Database Syst Rev. 2010(8):CD008169.
Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290-300.
Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012;59(6):1124-1131.
Salam A, Kanukula R, Atkins E. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(9):1768-1774.
- Burnier M. Renin-angiotensin system blockade in advanced kidney disease: stop or continue? Kidney Med. 2020;2(3):231-234.
Calhoun DA, Jones D, Textor S. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-1419.
Hirsch AT, Haskal ZJ, Hertzer NR. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-e654.
Olin JW, Froehlich J, Gu X. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182-3190.
Riaz IB, Husnain M, Riaz H. Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. Am J Cardiol. 2014;114(7):1116-1123.
Cooper CJ, Murphy TP, Cutlip DE. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13-22.
Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56(3):525-532.
Funder JW, Carey RM, Fardella C. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266-3281.
Funder JW, Carey RM, Mantero F. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889-1916.
Mulatero P, Stowasser M, Loh KC. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045-1050.
Montori VM, Young WF. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. [xi.]. Endocrinol Metab Clin North Am. 2002;31(3):619-632.
Parati G, Lombardi C, Hedner J. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30(4):633-646.
Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046-1053.
Nieto FJ, Young TB, Lind BK. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283(14):1829-1836.
Farney RJ, Walker BS, Farney RM, Snow GL, Walker JM. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med. 2011;7(5):459-465B.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545.
Chiu HY, Chen PY, Chuang LP. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev. 2017;36:57-70.
Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.
Martínez-García MÁ, Capote F, Campos-Rodríguez F. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407-2415.
Yeghiazarians Y, Jneid H, Tietjens JR. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56-e67. 2022;145(12):e775.
Lenders JM, Duh QY, Eisenhofer G. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942.
Hassan-Smith Z, Stewart PM. Inherited forms of mineralocorticoid hypertension. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):177-185.
Engvall J, Sonnhag C, Nylander E, Stenport G, Karlsson E, Wranne B. Arm-ankle systolic blood pressure difference at rest and after exercise in the assessment of aortic coarctation. Br Heart J. 1995;73(3):270-276.
Lurbe E, Cifkova R, Cruickshank JK. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719-1742.
Lurbe E, Agabiti-Rosei E, Cruickshank JK. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887-1920.
Flynn JT, Kaelber DC, Baker-Smith CM. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. 2018;142(3):e20181739.
Nugent JT, Young C, Funaro MC. Prevalence of secondary hypertension in otherwise healthy youths with a new diagnosis of hypertension: a meta-analysis. J Pediatr. 2022;244:30-37.e10.
Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874-879.
Dobson CP, Eide M, Nylund CM. Hypertension prevalence, cardiac complications, and antihypertensive medication use in children. J Pediatr. 2015;167(1):92.e1-97.e1.
Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension. 2013;62(2):247-254.
McNiece KL, Gupta-Malhotra M, Samuels J. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50(2):392-395.
Yang L, Magnussen CG, Yang L, Bovet P, Xi B. Elevated blood pressure in childhood or adolescence and cardiovascular outcomes in adulthood: a systematic review. Hypertension. 2020;75(4):948-955.
Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens. 2002;20(12):2317-2325.
Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS, Daniels SR. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics. 2007;119(2):237-246.
Rodgers A, Perkovic V. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2016;374(23):2295.
McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640-644.
Parker ED, Sinaiko AR, Kharbanda EO. Change in weight status and development of hypertension. Pediatrics. 2016;137(3):e20151662.
Smith DK, McMullan SM, Martin MJ. Getting hypertension under control in the youngest of patients. J Fam Pract. 2021;70(5):220-228.
Krist AH, Davidson KW, Mangione CM. Screening for high blood pressure in children and adolescents: U.S. Preventive Services Task Force recommendation statement. JAMA. 2020;324(18):1878-1883.
Gartlehner G, Vander Schaaf EB, Orr C, Kennedy SM, Clark R, Viswanathan M. Screening for hypertension in children and adolescents: updated evidence report and systematic review for the U.S. Preventive Services Task Force. JAMA. 2020;324(18):1884-1895.
Moyer VA. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics. 2013;132(5):907-914.
Flynn JT, Daniels SR, Hayman LL. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63(5):1116-1135.
National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-S256.
Flynn JT, Urbina EM, Brady TM. Ambulatory blood pressure monitoring in children and adolescents: 2022 update: a scientific statement from the American Heart Association. Hypertension. 2022;79(7):e114-e124.
American Academy of Family Physicians. Clinical preventive service recommendation. Hypertension https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/hypertension.html
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-576.
Rosner BF, Flynn JT. AAP pediatric hypertension guidelines https://www.mdcalc.com/aap-pediatric-hypertension-guidelines
Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR. Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis. Ann Intern Med. 2019;170(12):853-862.
Riley M, Hernandez AK, Kuznia AL. High blood pressure in children and adolescents. Am Fam Physician. 2018;98(8):486-494.
Killian L, Simpson JM, Savis A, Rawlins D, Sinha MD. Electrocardiography is a poor screening test to detect left ventricular hypertrophy in children. Arch Dis Child. 2010;95(10):832-836.
Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension. 2012;60(4):1047-1054.
Sladowska-Kozłowska J, Litwin M, Niemirska A, Wierzbicka A, Wawer ZT, Janas R. Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension. Pediatr Nephrol. 2011;26(12):2201-2209.
Moore LL, Bradlee ML, Singer MR, Qureshi MM, Buendia JR, Daniels SR. Dietary Approaches to Stop Hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls. Br J Nutr. 2012;108(9):1678-1685.
Grossman DC, Bibbins-Domingo K U.S. Preventive Services Task Force. Screening for obesity in children and adolescents: U.S. Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417-2426.
Bowen ME, Ray WA, Arbogast PG, Ding H, Cooper WO. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol. 2008;198(3):291.e1-291.e5.
Centers for Disease Control and Prevention. High blood pressure during pregnancy https://www.cdc.gov/bloodpressure/pregnancy.htm
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-644.
Wang W, Xie X, Yuan T. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7.
Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1-134.e8.
Davidson KW, Barry MJ, Mangione CM. Aspirin use to prevent preeclampsia and related morbidity and mortality: U.S. Preventive Services Task Force recommendation statement. JAMA. 2021;326(12):1186-1191.
Green TL, Zapata JY, Brown HW, Hagiwara N. Rethinking bias to achieve maternal health equity: changing organizations, not just individuals. Obstet Gynecol. 2021;137(5):935-940.
Miller EC, Zambrano Espinoza MD, Huang Y. Maternal race/ethnicity, hypertension, and risk for stroke during delivery admission. J Am Heart Assoc. 2020;9(3):e014775.
Bello NA, Woolley JJ, Cleary KL. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension. 2018;71(2):326-335.
Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH. Blood pressure measurement in pregnancy. Obstet Gynaecol. 2015;17(2):91-98.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133(1):e26-e50.
Gestational hypertension and preeclampsia: ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237-e260.
Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM. Maternal outcomes associated with lower range stage 1 hypertension. Obstet Gynecol. 2018;132(4):843-849.
Hypertension in pregnancy. American College of Obstetricians Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. ACOG; 2013.
Bibbins-Domingo K, Grossman DC, Curry SJ. Screening for preeclampsia: U.S. Preventive Services Task Force recommendation statement. JAMA. 2017;317(16):1661-1667.
American College of Obstetricians and Gynecologists. ACOG statement on USPSTF final recommendations on screening for preeclampsia https://www.acog.org/news/news-releases/2017/04/acog-statement-on-uspstf-final-recommendations-on-screening-for-preeclampsia
Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N. Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the U.S. Preventive Services Task Force. JAMA. 2021;326(12):1192-1206.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110.e6-120.e6.
ACOG Committee Opinion No. 743. Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-e52.
Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018(10):CD002252.
Magee LA, von Dadelszen P, Rey E. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407-417.
Tita AT, Szychowski JM, Boggess K. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386(19):1781-1792.
- American College of Obstetricians and Gynecologists. Practice advisory: clinical guidance for the integration of the findings of the Chronic Hypertension and Pregnancy (CHAP) study. 2022. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2022/04/clinical-guidance-for-the-integration-of-the-findings-of-the-chronic-hypertension-and-pregnancy-chap-study
Society for Maternal-Fetal Medicine statement: antihypertensive therapy for mild chronic hypertension in pregnancy—the Chronic Hypertension and Pregnancy trial. Am J Obstet Gynecol. 2022;227(2):B24-B27.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Indications for outpatient antenatal fetal surveillance. ACOG Committee Opinion, No 828. Obstet Gynecol. 2021;137(6):e177-e197.
American College of Obstetricians and Gynecologists. Antepartum fetal surveillance. Practice Bulletin No. 229. Obstet Gynecol. 2021;137(6):e116-e127.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Medically indicated late-preterm and early-term deliveries: ACOG Committee Opinion, No. 831. Obstet Gynecol. 2021;138(1):e35-e39.
ACOG Committee Opinion No. 736: optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140-e150.
Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy. 2003;22(2):109-127.